RT Journal
A1 Daniels SR
T1 USe of pharmacologic agents for treatment of diabetes mellitus, dyslipidemia, and hypertension in children and adolescents
JF Archives of Pediatrics & Adolescent Medicine
JO Archives of Pediatrics & Adolescent Medicine
YR 2009
FD April 6
VO 163
IS 4
SP 389
OP 391
DO 10.1001/archpediatrics.2008.575
UL http://dx.doi.org/10.1001/archpediatrics.2008.575
AB 
Cardiovascular disease is the number one cause of mortality in the adult population of the United States.1 Much of this is due to atherosclerotic cardiovascular disease. Recognition of these facts has led to national guidelines to control risk factors for cardiovascular disease, such as type 2 diabetes mellitus,2 dyslipidemia,3 and hypertension,4 and to the concept that recognition, treatment, and control of risk factors are important to prevent cardiovascular disease morbidity and mortality.2- 4 In fact, the decline in cardiovascular disease mortality over the last 50 years has been attributed to both better control of risk factors and better intensive care in the treatment of acute events.5